BCV
GILD icon

Banque Cantonale Vaudoise’s Gilead Sciences GILD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.06K Sell
63,781
-11,997
-16% -$1.58M ﹤0.01% 236
2026
Q1 		$10.6M Buy
75,778
+4,814
+7% +$674K 0.4% 40
2025
Q4 		$8.71M Sell
70,964
-9,314
-12% -$1.13M 0.31% 51
2025
Q3 		$8.91M Sell
80,278
-16,310
-17% -$1.85M 0.33% 49
2025
Q2 		$10.7M Sell
96,588
-9,863
-9% -$1.05M 0.44% 35
2025
Q1 		$11.9M Buy
+106,451
New +$11M 0.53% 28
2024
Q3 		$12.4M Buy
148,490
+159
+0.1% +$12.1K 0.51% 32
2024
Q2 		$10.2M Buy
148,331
+20,465
+16% +$1.37M 0.4% 40
2024
Q1 		$9.37M Buy
127,866
+19,030
+17% +$1.46M 0.37% 47
2023
Q4 		$8.82M Buy
108,836
+5,733
+6% +$446K 0.38% 45
2023
Q3 		$7.73M Sell
103,103
-15,099
-13% -$1.16M 0.39% 47
2023
Q2 		$9.11M Sell
118,202
-26,530
-18% -$2.12M 0.42% 41
2023
Q1 		$12M Buy
144,732
+3,565
+3% +$295K 0.59% 27
2022
Q4 		$12.1M Buy
141,167
+14,784
+12% +$1.17M 0.63% 25
2022
Q3 		$7.8M Sell
126,383
-2,496
-2% -$157K 0.44% 39
2022
Q2 		$7.97M Sell
128,879
-7,431
-5% -$460K 0.41% 43
2022
Q1 		$8.1M Buy
136,310
+10,775
+9% +$689K 0.35% 54
2021
Q4 		$9.11M Buy
125,535
+3,469
+3% +$239K 0.36% 47
2021
Q3 		$8.53M Sell
122,066
-4,130
-3% -$290K 0.37% 46
2021
Q2 		$8.69M Sell
126,196
-4,750
-4% -$317K 0.39% 38
2021
Q1 		$8.46M Buy
130,946
+1,505
+1% +$97K 0.43% 36
2020
Q4 		$7.54M Buy
129,441
+7,006
+6% +$423K 0.42% 46
2020
Q3 		$7.73M Buy
122,435
+29,290
+31% +$2.03M 0.5% 38
2020
Q2 		$7.17M Sell
93,145
-7,198
-7% -$552K 0.52% 33
2020
Q1 		$7.5M Buy
100,343
+2,422
+2% +$167K 0.64% 29
2019
Q4 		$6.37M Buy
+97,921
New +$6.38M 0.44% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banque Cantonale Vaudoise's GILD Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its Gilead Sciences (GILD) stake by 16% in Q2 2026, selling an estimated $1.58M and leaving 63,781 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Banque Cantonale Vaudoise first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $12.4M in Q3 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Banque Cantonale Vaudoise held 63,781 shares of Gilead Sciences worth $8.06K as of Q2 2026.
  • Banque Cantonale Vaudoise sold 11,997 Gilead Sciences shares in Q2 2026, an estimated $1.58M.
  • Gilead Sciences made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #236 holding.
  • Banque Cantonale Vaudoise first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Gilead Sciences position peaked at $12.4M in Q3 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.